Recent Material Events - Aspreva Pharmaceutic (ASPV)

Filing Date	Description
2008-01-08	As a result of the completion of the Plan of Arrangement, Aspreva became a wholly-owned subsidiary of Galenica AG. The aggregate consideration paid pursuant to the Plan of Arrangement and the Combination Agreement was approximately US$943,213,794 ...
2007-12-24	On December 21, 2007 Aspreva Pharmaceuticals Corporation announced that the Minister of Industry, under the Investment Canada Act, has approved the acquisition of Aspreva by Galenica AG, through Galenica Canada Ltd., a wholly-owned Canadian subsi ...
2007-12-19	On December 18, 2007, the British Columbia Supreme Court issued a final order approving a statutory plan of arrangement under the Business Corporations Act (British Columbia), pursuant to which Galenica AG, through Galenica Canada Ltd., a wholly- ...
2007-12-17	On December 17, 2007, the shareholders and optionholders of Aspreva Pharmaceuticals approved a statutory plan of arrangement under the Business Corporations Act (British Columbia), pursuant to which Galenica AG, through Galenica Canada Ltd., a wh ...
2007-11-23	On November 23, 2007, Aspreva Pharmaceuticals Corporation filed a Management Information Circular for its Special Meeting of Securityholders to be held on December 17, 2007, which is attached hereto as Exhibit 99.1. ...
2007-10-23	On October 17, 2007, the board of directors of Aspreva Pharmaceuticals Corporation approved a one-time cash payment of US$58,500 to each of our non-employee directors plus an additional one-time cash payment of US$58,500 to our lead director, in lie ...
2007-10-18	On October 17, 2007, Aspreva Pharmaceuticals Corporation (“Aspreva”) entered into a definitive Combination Agreement (the “Combination Agreement”) with Galenica AG, a diversified global healthcare company headquartered in Bern, Sw ...
2007-10-17	On October 16, 2007, Aspreva Pharmaceuticals Corporation issued a press release announcing its preliminary revenues for the quarter ended September 30, 2007. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by refe ...
2007-09-26	On September 24, 2007, Aspreva Pharmaceuticals Corporation entered into a Letter Agreement amending that certain Executive Employment Agreement, dated January 6, 2007, the Employment Agreement, and that certain Change of Control Agreement, dated ...
2007-09-11	On September 10, 2007, Aspreva Pharmaceuticals Corporation issued a press release announcing updates on the lupus nephritis development program. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. ...